MISSISSAUGA, ON, February 25, 2021 / PRNewswire / – Novo Nordisk yesterday launched a global healthcare company with Canadian headquarters in Mississauga, and the University of Toronto (U of T) announced a new research center at U of T’s Mississauga Campus where leading public health experts come together to reduce chronic illnesses around the world.
“We are thrilled that Novo Nordisk and U of T have chosen Mississauga as the home of their new research network, which will support our goal of creating a healthier city and world, “said the mayor Bonnie Crombie. “In the Peel region, every tenth inhabitant lives with diabetes, which is 40 percent more than the rest of the region Ontario. We understand that there is a direct link between healthy citizens and the economic productivity of society. Unfortunately, COVID-19 has affected people at risk – like those suffering from chronic illness – more. That’s why we support research in our community to improve the health of our residents and people around the world. “
As part of the City of Mississauga Two webinars were held in 2020 and 2021 to educate community stakeholders on how we can work together to put health at the heart of city politics and support a healthier society.
“This partnership complements that City of Mississauga The Economic Development Strategy, which highlights the importance of creating initiatives to support healthy lifestyles, as well as the Life Science Clusters strategy, which encourages innovation between stakeholders, “said Harold Dremin, Deputy Director for Economic Development at the City of Mississauga. “”Mississauga is home to many newcomers Canada and the largest community-based hospital system in the country, which is why we offer researchers a unique opportunity to investigate the root cause of rising type 2 diabetes in a very diverse setting. “
Novo Nordisk and U of T have invested $ 20 million each to build the Novo Nordisk Healthy Population Network, a network of experts that will draw on leading U of T public health research. The network plans to investigate critical problems related to chronic diseases, research and support new technologies such as virtual nursing and distance learning, and develop interventions to prevent unsustainable increases in chronic diseases.
“It takes much more than innovative medicine to achieve our company’s goal of combating diabetes, obesity and other serious chronic diseases,” said Béatrice Clerc, President of Novo Nordisk Canada. “One hundred years after the discovery of insulin, we are proud to partner with U of T again to help society eradicate the causes of type 2 diabetes and obesity.”
This network will be a partnership between the Dalla Lana School of Public Health, the Temerty Faculty of Medicine and U of T Mississauga.
“The historic investment will build research and teaching capacity at the University of T. It will bring together existing expertise from across the university and our partners in the health sector Mississauga and the wider region, “said U of T President Meric Gertler. “Ultimately, this will usher in a new era of hope for people faced with diabetes and other chronic diseases here in diabetes Canadaand all over the world. “
SOURCE City of Mississauga
similar links
https://mississauga.ca/
